Vertex Pharmaceuticals Inc. buy UBS Group AG
Start price
17.10.24
/
50%
€459.95
Target price
17.10.25
€519.06
Performance (%)
-27.98%
Price
06.08.25
€331.25
Summary
This prediction is currently active. The price of Vertex Pharmaceuticals Inc. has decreased since the start of the prediction. Compared to the start price this results in a performance of -27.98%. This prediction currently runs until 17.10.25. The prediction end date can be changed by UBS_Group_AG at any time. UBS_Group_AG has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Vertex Pharmaceuticals Inc. | -20.138% | -20.138% |
| iShares Core DAX® | -1.351% | 0.610% |
| iShares Nasdaq 100 | -1.453% | 3.019% |
| iShares Nikkei 225® | -0.021% | 1.195% |
| iShares S&P 500 | -1.326% | 2.830% |
Comments by UBS_Group_AG for this prediction
In the thread Vertex Pharmaceuticals Inc. diskutieren
Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX) had its price target raised by analysts at UBS Group AG from $477.00 to $562.00. They now have a "buy" rating on the stock.
Ratings data for VRTX provided by MarketBeat
Stopped prediction by UBS_Group_AG for Vertex Pharmaceuticals Inc.
Vertex Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€344.35
05.08.25
05.08.25
€478.40
05.08.26
05.08.26
-3.80%
06.08.25
06.08.25
Vertex Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€459.85
05.11.24
05.11.24
€536.01
05.11.25
05.11.25
-27.97%
06.08.25
06.08.25